ArticleBMC pregnancy and childbirth2026
ABOVE: cerclage after caesarean: protocol for a randomised controlled trial to assess the optimal preventative management for preterm birth secondary to caesarean section damage.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThere is emerging evidence that caesarean section in labour is associated with an increased risk of recurrent mid-trimester loss (MTL) and spontaneous preterm birth (sPTB) in subsequent pregnancies. This is likely due to inadvertent damage to the cervical tissue at the time of caesarean section. Transvaginal cerclage (TVC) has been demonstrated to be less successful in this high-risk cohort of women. However, transabdominal cerclage (TAC) may be more effective as the suture is placed above the level of cervical caesarean damage. A TAC can be placed before or during early pregnancy, although placement during pregnancy may be less effective. To determine the optimal clinical management for women with this risk factor, the ABOVE trial will evaluate the effectiveness of TAC compared to TVC in women who have experienced a MTL or sPTB following an in-labour caesarean section.
methodsABOVE is a multicentre randomised control trial comparing TAC or TVC as a preventative strategy for sPTB in women with history of an in-labour CS and subsequent MTL (14+ 0 -23+ 6 weeks) or sPTB (< 30 weeks). Participants will be allocated to one of two groups - Group A (currently pregnant < 14 weeks’ gestation) and Group B (planning a pregnancy) - and randomised 1:1 to TAC or TVC within each group. DISCUSSION: The ABOVE trial will investigate the efficacy of known interventions in the prevention of preterm birth, TVC and TAC, in women who have had a previous in-labour CS and subsequent MTL or sPTB. The trial will inform the development of evidence-based practice guidelines to optimise the care offered to this cohort of high-risk women. With escalating rates of CS and the increased recognition of the relationship between caesarean cervical damage and sPTB and MTL, this work is key.
trial registrationISCRTN 10977996 (17/05/2024).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.